Brief: Bioarctic Says Leqembi Approved For IV Maintenance Treatment In United Kingdom
13/11/2025 23:31
Nov 13 (Reuters) - BioArctic AB BIOAb.ST: BIOARCTIC AB - LEQEMBI® APPROVED FOR IV MAINTENANCE TREATMENT IN UNITED KINGDOM Source text: ID:nWkr182mch Further company coverage: [BIOAb.ST] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million